Sin categoría – Página 14 – SEIOMM, Sociedad Española de Investigación Ósea

Role of Bone Morphogenetic Protein 2 Polymorphisms in Bone Mineral Density after the Start of Treatment with Atorvastatin.

Basic Clin Pharmacol Toxicol. 2018 Dec;123(6):766-769. doi:10.1111/bcpt.13086. Usategui-Martín R, Vega G, Abad-Manteca L, Ruiz-Mambrilla M, Calero-Paniagua I, Dueñas-Laita A, Pérez-Castrillón JL.

Efficacy, cost, and aspects to take into account in the treatment of osteoporosis in the elderly.

Rev Esp Geriatr Gerontol. 2018 Dec 31. pii: S0211-139X(18)30716-9. doi: 10.1016/j.regg.2018.11.007. Review. Sáez-López P, Etxebarria-Foronda I, Mesa Lampre MP, Alonso García N, Sánchez Hernández N.

Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON-PFT Extension I Trials.

J Bone Miner Res. 2018 Dec 7. doi: 10.1002/jbmr.3654. [Epub ahead of print] DOI: 10.1002/jbmr.3654 -PMID: 30536713 Kim TY(1)(2), Bauer DC(1)(3), McNabb BL(1), Schafer AL(1)(3)(2), Cosman F(4)(5), Black DM(3), Eastell R(6).

One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study.

J Bone Miner Res. 2018 Dec 3. doi: 10.1002/jbmr.3622. [Epub ahead of print] DOI: 10.1002/jbmr.3622 -PMID: 30508316 Lewiecki EM(1), Dinavahi RV(2), Lazaretti-Castro M(3), Ebeling PR(4), Adachi JD(5), Miyauchi A(6), Gielen E(7), Milmont CE(2), Libanati C(8), … Leer más

Hip fracture rates and time trends in use of anti-osteoporosis medications in Denmark for the period 2005 to 2015: Missed opportunities in fracture prevention.

Bone. 2018 Dec 21;120:476-481. doi: 10.1016/j.bone.2018.12.016. [Epub ahead of print] DOI: 10.1016/j.bone.2018.12.016 -PMID: 30583122 Abrahamsen B(1), Skjødt MK(2), Vestergaard P(3). https://www.ncbi.nlm.nih.gov/pubmed/30583122

Acute hypercalcemia and excessive bone resorption following anti-RANKL withdrawal: Case report and brief literature review.

Bone. 2018 Dec 17;120:482-486. doi: 10.1016/j.bone.2018.12.012. [Epub ahead of print] DOI: 10.1016/j.bone.2018.12.012 -PMID: 30572144 Roux S(1), Massicotte MH(2), Huot Daneault A(3), Brazeau-Lamontagne L(4), Dufresne J(5).

Effect of Sarcopenia on Postoperative Mortality in Osteoporotic Hip Fracture Patients.

J Bone Metab. 2018 Nov;25(4):227-233. doi: 10.11005/jbm.2018.25.4.227. Epub 2018 DOI: 10.11005/jbm.2018.25.4.227 -PMCID: PMC6288605 -PMID: 30574467 Kim YK, Yi SR, Lee YH, Kwon J, Jang SI, Park SH. https://www.ncbi.nlm.nih.gov/pubmed/30574467

Bone management in hematologic stem cell transplant recipients

Foundation Committee of Scientific Advisors Working Group on Cancer and Bone Disease.. Osteoporos Int. 2018 Sep 3. Kendler DL, Body JJ, Brandi ML, Broady R, Cannata-Andia J, Cannata-Ortiz MJ, El Maghraoui A, Guglielmi G, Hadji … Leer más

Adding Lateral Spine Imaging for Vertebral Fractures to Densitometric Screening: Improving Ascertainment of Patients at High Risk of Incident Osteoporotic Fractures.

J Bone Miner Res. 2018 Nov 5. doi: 10.1002/jbmr.3595. [Epub ahead of print] Prince RL(1)(2), Lewis JR(1)(3)(4), Lim WH(1)(5), Wong G(3), Wilson KE(6), Khoo BC(1)(7), Zhu K(1)(2), Kiel DP(8), Schousboe JT(9). DOI: 10.1002/jbmr.3595 -PMID: 30395687

Fall-risk increasing drugs and prevalence of polypharmacy in older patients discharged from an Orthogeriatric Unit after a hip fracture.

Aging Clin Exp Res. 2018 Oct 1. doi: 10.1007/s40520-018-1046-2. [Epub ahead of print] Correa-Pérez A, Delgado-Silveira E, Martín-Aragón S, Rojo-Sanchís AM,Cruz-Jentoft AJ. https://www.ncbi.nlm.nih.gov/pubmed/30276631